Leptomeningeal metastatic hormone receptor positive, HER2 and PD-L1 negative, breast cancer responds after pembrolizumab added to abemaciclib: A case study

Bibliographic Details
Main Authors:	Melissa Mahoney, Frankie Ann Holmes, Benjamin Cho
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	Current Problems in Cancer: Case Reports
Subjects:	Metastatic breast cancer Leptomeningeal disease Pembrolizumab Abemaciclib PDL-1
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666621920300338

Internet